These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31704453)

  • 1. Inflammasome and α-synuclein in Parkinson's disease: A cross-sectional study.
    Chatterjee K; Roy A; Banerjee R; Choudhury S; Mondal B; Halder S; Basu P; Shubham S; Dey S; Kumar H
    J Neuroimmunol; 2020 Jan; 338():577089. PubMed ID: 31704453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease.
    Fan Z; Pan YT; Zhang ZY; Yang H; Yu SY; Zheng Y; Ma JH; Wang XM
    J Neuroinflammation; 2020 Jan; 17(1):11. PubMed ID: 31915018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein evokes NLRP3 inflammasome-mediated IL-1β secretion from primary human microglia.
    Pike AF; Varanita T; Herrebout MAC; Plug BC; Kole J; Musters RJP; Teunissen CE; Hoozemans JJM; Bubacco L; Veerhuis R
    Glia; 2021 Jun; 69(6):1413-1428. PubMed ID: 33506583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of NLRP3 Inflammasome in Parkinson's Disease and Therapeutic Considerations.
    Nguyen LTN; Nguyen HD; Kim YJ; Nguyen TT; Lai TT; Lee YK; Ma HI; Kim YE
    J Parkinsons Dis; 2022; 12(7):2117-2133. PubMed ID: 35988226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
    Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
    Front Immunol; 2021; 12():719807. PubMed ID: 34691027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2X7 receptor/NLRP3 inflammasome complex and α-synuclein in peripheral blood mononuclear cells: a prospective study in neo-diagnosed, treatment-naïve Parkinson's disease.
    Solini A; Rossi C; Santini E; Giuntini M; Raggi F; Parolini F; Biancalana E; Del Prete E; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2021 Aug; 28(8):2648-2656. PubMed ID: 33991356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From inflammasome to Parkinson's disease: Does the NLRP3 inflammasome facilitate exosome secretion and exosomal alpha-synuclein transmission in Parkinson's disease?
    Si XL; Fang YJ; Li LF; Gu LY; Yin XZ; Jun-Tian ; Yan YP; Pu JL; Zhang BR
    Exp Neurol; 2021 Feb; 336():113525. PubMed ID: 33161049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.
    Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G
    Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
    Wang S; Yuan YH; Chen NH; Wang HB
    Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 Inflammasomes in Parkinson's disease and their Regulation by Parkin.
    Yan YQ; Fang Y; Zheng R; Pu JL; Zhang BR
    Neuroscience; 2020 Oct; 446():323-334. PubMed ID: 32795556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson's Disease.
    Han QQ; Le W
    Neurosci Bull; 2023 May; 39(5):832-844. PubMed ID: 36757612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Expression of the NOD-like Receptor Family, Pyrin Domain Containing 3 Inflammasome in Dermatomyositis and Polymyositis is a Potential Contributor to Their Pathogenesis.
    Yin X; Han GC; Jiang XW; Shi Q; Pu CQ
    Chin Med J (Engl); 2016 May; 129(9):1047-52. PubMed ID: 27098789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay between α-Synuclein and NLRP3 inflammasome in Parkinson's disease.
    Huang Q; Yang P; Liu Y; Ding J; Lu M; Hu G
    Biomed Pharmacother; 2023 Dec; 168():115735. PubMed ID: 37852103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation.
    Chen CM; Yen CY; Chen WL; Lin CH; Wu YR; Chang KH; Lee-Chen GJ
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson's disease.
    Grotemeyer A; Fischer JF; Koprich JB; Brotchie JM; Blum R; Volkmann J; Ip CW
    J Neuroinflammation; 2023 Mar; 20(1):79. PubMed ID: 36945016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.
    Codolo G; Plotegher N; Pozzobon T; Brucale M; Tessari I; Bubacco L; de Bernard M
    PLoS One; 2013; 8(1):e55375. PubMed ID: 23383169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease.
    Gustot A; Gallea JI; Sarroukh R; Celej MS; Ruysschaert JM; Raussens V
    Biochem J; 2015 Nov; 471(3):323-33. PubMed ID: 26272943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-synuclein promotes progression of Parkinson's disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome.
    Wang X; Chi J; Huang D; Ding L; Zhao X; Jiang L; Yu Y; Gao F
    Exp Ther Med; 2020 Feb; 19(2):931-938. PubMed ID: 32010254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic inhibition of NLRP3 reduces the levels of α-synuclein and protects dopaminergic neurons in a model of Parkinson's disease.
    Amo-Aparicio J; Daly J; Højen JF; Dinarello CA
    J Neuroinflammation; 2023 Jun; 20(1):147. PubMed ID: 37349821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammasome Activation in Parkinson's Disease.
    Jewell S; Herath AM; Gordon R
    J Parkinsons Dis; 2022; 12(s1):S113-S128. PubMed ID: 35848038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.